117 related articles for article (PubMed ID: 3498910)
1. Lymphocyte populations in premalignant lesions and cancer of the oral cavity.
Pillai MR; Balaram P; Abraham T; Nair MK
Neoplasma; 1987; 34(4):469-79. PubMed ID: 3498910
[TBL] [Abstract][Full Text] [Related]
2. Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations.
Ralhan R; Nath N; Agarwal S; Mathur M; Wasylyk B; Shukla NK
Clin Cancer Res; 1998 Sep; 4(9):2147-52. PubMed ID: 9748133
[TBL] [Abstract][Full Text] [Related]
3. Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer. II. Lymphocyte subpopulations.
Balaram P; Padmanabhan TK; Vasudevan DM
Neoplasma; 1988; 35(2):235-42. PubMed ID: 3259681
[TBL] [Abstract][Full Text] [Related]
4. [Changes of peripheral lymphocyte subsets in patients with oral squamous carcinoma].
Moroyama T; Endo K; Hazutani J; Iwao I; Shiratsuki T; Mitsui K; Sugihara K; Okahara Y; Hara J; Sakamoto T
Gan No Rinsho; 1985 Feb; 31(2):117-21. PubMed ID: 3157809
[TBL] [Abstract][Full Text] [Related]
5. [The numbers and distribution studies of natural killer cell, T cell subsets in peripheral blood and local infiltration in patients with squamous cell carcinoma of the oral cavity].
Pan L
Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 Jul; 27(4):225-7. PubMed ID: 1303835
[No Abstract] [Full Text] [Related]
6. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune profile in patients with pre-cancer and cancer of the cervix: a cross sectional study among Indian women.
Gupta MM; Jain R; Parashari A; Singh V; Sharma S
Bull Cancer; 1993 Oct; 80(10):852-6. PubMed ID: 8204922
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of a blood group antigen precursor in oral premalignant lesions.
Dabelsteen E; Vedtofte P; Hakomori S; Young WW
Cancer Res; 1983 Mar; 43(3):1451-4. PubMed ID: 6825113
[TBL] [Abstract][Full Text] [Related]
9. [Immunopathological findings in precancerous and carcinomatous conditions of the oral mucosa (author's transl)].
Djawari D; del Castillo-Carillo LF; Simon M; Hornstein OP
Dtsch Med Wochenschr; 1981 Oct; 106(40):1289-93. PubMed ID: 6974090
[No Abstract] [Full Text] [Related]
10. Anti-p53 and anti-heat shock proteins antibodies in patients with malignant or pre-malignant lesions of the oral cavity.
Castelli M; Cianfriglia F; Manieri A; Palma L; Pezzuto RW; Falasca G; Delpino A
Anticancer Res; 2001; 21(1B):753-8. PubMed ID: 11299839
[TBL] [Abstract][Full Text] [Related]
11. Progressive rise of c fos expression from premalignant to malignant lesions of oral cavity.
Sachdev R; Mandal AK; Singh I; Agarwal AK
Med Oral Patol Oral Cir Bucal; 2008 Nov; 13(11):E683-6. PubMed ID: 18978706
[TBL] [Abstract][Full Text] [Related]
12. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
13. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma.
Rhodus NL; Ho V; Miller CS; Myers S; Ondrey F
Cancer Detect Prev; 2005; 29(1):42-5. PubMed ID: 15734216
[TBL] [Abstract][Full Text] [Related]
15. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients.
van der Meij EH; Mast H; van der Waal I
Oral Oncol; 2007 Sep; 43(8):742-8. PubMed ID: 17112770
[TBL] [Abstract][Full Text] [Related]
16. Serum circulating immune complexes as prognostic indicators in premalignant and malignant lesions of oral cavity during and following radiotherapy.
Rai S; Mody RN
J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S116-22. PubMed ID: 22322729
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of T- and B-lymphocytes in peripheral blood of patients with solid tumours. I. Relation to other parameters of in vivo and in vitro immune competence.
Harris J; Stewart T; Sengar DP; Hyslop D
Can Med Assoc J; 1975 Apr; 112(8):948-52. PubMed ID: 1079472
[TBL] [Abstract][Full Text] [Related]
18. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
19. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
20. [Distant metastases from carcinoma of the oral cavity and pharynx].
Oizumi Y; Tamai Y; Fukuhara N; Mori T
Gan No Rinsho; 1986 Jul; 32(8):855-60. PubMed ID: 3747147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
